ビタミンK摂取量多→心血管疾患低下 過去研究支持 K2:心血管健康で無視 https://t.co/LJuRD4RnSN K2:抗Ca蛋白 マトリックスGLA蛋白の活性化→Ca調節 K2補給→全身石灰化と動脈硬化を調節→心臓病転帰改善 未透析CKD動脈硬化にK2 https://t.co/qhg03pUaRH 動脈硬化症進行減 必ず灰化進行を示さず
Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2019 – Aug 2024Where it's discussed
-
X / Twitter17 posts
-
Facebook4 posts
-
News3 articles
-
YouTube2 videos
AI synopsis
What people are saying
Discussions reflect mixed reactions, with some posts emphasizing the potential health benefits of vitamin K2, using words like 'promising' and 'beneficial,' while others express skepticism with phrases like 'yet we have these'; the tone varies between curiosity and doubt, illustrating moderate engagement and differing perceptions of impact.
Most discussions support the findings, with some expressing skepticism, especially regarding efficacy.
Overall interest appears neutral, with some posts highlighting potential benefits and others questioning significance.
Many posts reference specific details like calcium levels and CDT, showing moderate engagement, but some dismiss the importance, reducing depth.
The influence of the publication is seen as modest; it sparks discussion but lacks widespread urgency or strong advocacy.
Abstract in brief
- The study found that taking vitamin K2 for about 9 months may help slow down the progression of atherosclerosis in patients with stage 3-5 chronic kidney disease, but it doesn't significantly stop vascular calcification.
- Patients who received vitamin K2 showed a smaller increase in carotid artery thickness (CCAIMT) compared to those who didn't, indicating less progression of arterial thickening.
- Vitamin K2 also altered levels of certain proteins involved in calcification, such as reducing dpucMGP and osteocalcin, which are linked to promoting or inhibiting calcification in blood vessels.]
Top posts
Most liked on X and BlueskyVitamin K2 supplementation is a viable and promising option to improve cardiovascular outcomes by reduces arterial calcification and improve insulin resistance in the body. (Links : •https://t.co/J6rqoO980g •https://t.co/XI3xn6JCTZ) https://t.co/HPSn0iQhvy
@Owtovit @NaturallyFTW @mbeauchamp1959 This study elucidates on the benefits... https://t.co/c1osGX25Yo
Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5. - PubMed - NCBI https://t.co/61zeOesM3F
重度冠動脈石灰化(CAC)患者 vit K2/D3補給 https://t.co/i9Sq7CqyqR 無作為化 placebo vs vit K2 720μg/日+vit D3 25μg/日 →重度CAC進行⬇️仮説を検証 用量はCAC>400で有効性が実証 https://t.co/8ajMIvS3Sdに基づく 2年間追跡は短過ぎ? https://t.co/QG2MX2IVVK vit K2+vit D→頸動脈中膜厚IMT⬆️が⬇️ https://t.co/5V3OfPtpOH
Atherosclerosis is significantly correlated with macular degen. Get your K2 Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in non-dialyzed patients with chronic kidney disease stage 35 (Kurnatowska I, et al) - K2 Vitamin https://t.co/QLkEfMyj2I
All mentions
Vitamin K2's Role in Slowing Atherosclerosis in Chronic Kidney Disease Patients
This study investigates how taking vitamin K2 for about 9 months may help slow atherosclerosis progression in stage 3-5 CKD patients, with less arterial thickening observed, though it has limited effect on vascular…
Exploring Vitamin K2: Effects on Bone and Heart Health
In this video, I dive deep into the science behind Vitamin K2 and its impact on bone health and heart health. I will unpack its key functions, including maintaining bone health and preventing arterial calcium buildup…
@Owtovit @NaturallyFTW @mbeauchamp1959 This study elucidates on the benefits... https://t.co/c1osGX25Yo
@MarkNeugebaue13 And yet we have things like this
RT @keisuke4713: 重度冠動脈石灰化(CAC)患者 vit K2/D3補給 https://t.co/i9Sq7CqyqR 無作為化 placebo vs vit K2 720μg/日+vit D3 25μg/日 →重度CAC進行⬇️仮説を検証 用量はCAC>40…
RT @keisuke4713: 重度冠動脈石灰化(CAC)患者 vit K2/D3補給 https://t.co/i9Sq7CqyqR 無作為化 placebo vs vit K2 720μg/日+vit D3 25μg/日 →重度CAC進行⬇️仮説を検証 用量はCAC>40…
重度冠動脈石灰化(CAC)患者 vit K2/D3補給 https://t.co/i9Sq7CqyqR 無作為化 placebo vs vit K2 720μg/日+vit D3 25μg/日 →重度CAC進行⬇️仮説を検証 用量はCAC>400で有効性が実証 https://t.co/8ajMIvS3Sdに基づく 2年間追跡は短過ぎ? https://t.co/QG2MX2IVVK vit K2+vit D→頸動脈中膜厚IMT⬆️が⬇️ https://t.co/5V3OfPtpOH
RT @Nutrition_1M: Vitamin K2 supplementation is a viable and promising option to improve cardiovascular outcomes by reduces arterial calcif…
RT @Nutrition_1M: Vitamin K2 supplementation is a viable and promising option to improve cardiovascular outcomes by reduces arterial calcif…
RT @Nutrition_1M: Vitamin K2 supplementation is a viable and promising option to improve cardiovascular outcomes by reduces arterial calcif…
Vitamin K2 supplementation is a viable and promising option to improve cardiovascular outcomes by reduces arterial calcification and improve insulin resistance in the body. (Links : •https://t.co/J6rqoO980g •https://t.co/XI3xn6JCTZ) https://t.co/HPSn0iQhvy
@Apple___BITES @patricksavalle 2de hit https://t.co/XNNwpaeoud
@ElenaSgarbossa @DeanOrnishMD @DrEsselstyn @RipEsselstyn https://t.co/XeWnWq6lhA
RT @keisuke4713: ビタミンK摂取量多→心血管疾患低下 過去研究支持 K2:心血管健康で無視 https://t.co/LJuRD4RnSN K2:抗Ca蛋白 マトリックスGLA蛋白の活性化→Ca調節 K2補給→全身石灰化と動脈硬化を調節→心臓病転帰改善 未透…
RT @keisuke4713: ビタミンK摂取量多→心血管疾患低下 過去研究支持 K2:心血管健康で無視 https://t.co/LJuRD4RnSN K2:抗Ca蛋白 マトリックスGLA蛋白の活性化→Ca調節 K2補給→全身石灰化と動脈硬化を調節→心臓病転帰改善 未透…
https://t.co/ci1GYqBlpB https://t.co/m5gEOohB5p
ビタミンK摂取量多→心血管疾患低下 過去研究支持 K2:心血管健康で無視 https://t.co/LJuRD4RnSN K2:抗Ca蛋白 マトリックスGLA蛋白の活性化→Ca調節 K2補給→全身石灰化と動脈硬化を調節→心臓病転帰改善 未透析CKD動脈硬化にK2 https://t.co/qhg03pUaRH 動脈硬化症進行減 必ず灰化進行を示さず
Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5. - PubMed - NCBI https://t.co/61zeOesM3F
Atherosclerosis is significantly correlated with macular degen. Get your K2 Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in non-dialyzed patients with chronic kidney disease stage 35 (Kurnatowska I, et al) - K2 Vitamin https://t.co/QLkEfMyj2I
T
HN
JO
DU
JS
つ
T
NI
SA
Q
Tט
PR
AS
三
CD